During Friday’s session, “WFH Educational: Treatments for bleeding disorders—current environment and pipeline products” moderated by Radoslaw Kaczmarek, participants learned about what new treatments are on the market and which ones are in store for the near future. The session was developed by the WFH Coagulation Product Safety, Supply, and Access (CPSSA) Committee.
Flora Peyvandi, MD, gave an overview of new products on the market and those in the pipeline. Dan Hart, MD, reviewed emicizumab and other novel products in neonates and previously untreated patients (PUPs). Radoslaw Kaczmarek covered lessons learned in communicating product (non)safety issues and Johnny Mahlangu, MD, spoke about new access opportunities in the changing treatment landscape.
To watch sessions from the WFH Virtual Summit – Connecting the Global Bleeding Disorders Community, please click here.